Veena Ranganath, MD
Enriched profileProfessor of Clinical Medicine (Rheumatology) and Professor of Clinical, Computational Medicine · University of California, Los Angeles (UCLA)
Veena Ranganath is Professor of Clinical Medicine (Rheumatology) and Professor of Clinical, Computational Medicine at University of California, Los Angeles (UCLA). OpenAlex indexes 102 publications with 3,532 citations (h-index 28); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Veena Ranganath, MD, is Professor of Clinical Medicine (Rheumatology) and Professor of Clinical, Computational Medicine at University of California, Los Angeles (UCLA), David Geffen School of Medicine / UCLA Health, Division of Rheumatology. The public record shows 102 publications with 3,532 citations (h-index 28), centered on Rheumatoid Arthritis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (2010–2014).
- Most recent indexed publication: 2026 · Clinical rheumatology
- Top research focus: Rheumatoid Arthritis
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Therapeutic Response of Cannabidiol in Rheumatoid Arthritis
Sponsor: University of California, Los Angeles
- Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet
Sponsor: Veena Ranganath, MD, MS
- Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
Sponsor: Veena Ranganath, MD, MS
Industry payments
Updated 16 Oct 2026
7 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20254 payments
- Janssen Biotech, Inc.Program year20251 payment
- Eli Lilly and CompanyProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
71.6%Folate Analog Metabolic Inhibitor23.7%Methotrexate100%Part D≥14 patientsTNF inhibitor20.7%Enbrel Sureclick52%Humira Pen25%Humira(Cf) Pen23%Part D<11 patients+ 3 more classes in this area
Antiparasitic
13.4%Antimalarial13.4%Hydroxychloroquine Sulfate100%Part D<11 patientsMetabolism & gastrointestinal
10.3%Corticosteroid10.3%Prednisone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
1 NIH research award on record, funded 2010–2014 per NIH RePORTER. The latest:
- Biomarkers for Early Therapeutic Response in Older RA Patients
University of California Los Angeles
FY2014$121,230K23AR057818 - Biomarkers for Early Therapeutic Response in Older RA Patients
University of California Los Angeles
FY2013$121,230K23AR057818 - Biomarkers for Early Therapeutic Response in Older RA Patients
University of California Los Angeles
FY2013$1,000K23AR057818
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemic.
Clinical rheumatology
Article2026 - Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis.
ACR open rheumatology
Article2025 - Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis.
Rheumatology international
Article2023 - Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial.
Rheumatology (Oxford, England)
Clinical Trial2023 - Impact of Perceived Stress During the SARS-CoV-2 Pandemic on Rheumatoid Arthritis Patients' Disease Activity: An Online Survey.
Journal of clinical rheumatology
Article2022
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/veena-ranganath-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
profiles.ucla.edu/veena.ranganath
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗ - LinkedIn
linkedin.com/in/veena-ranganath-91b79320
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- RhMSUS (Rheumatology Musculoskeletal Ultrasound Certification)
American College of Rheumatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →compmed.ucla.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Secondary affiliations
appointments beyond the home institution- Co-Director
Training Program in Translational Science (TPTS) Track 3 / UCLA Masters of Science in Clinical Research Program (MSCR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →compmed.ucla.edu ↗ - Director
Rheumatology Fellowship Musculoskeletal Ultrasound Training Program, UCLA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Marder, MD
University of California, Los Angeles (UCLA)
Steven Cramer, MD
University of California, Los Angeles (UCLA)
Rhonda Voskuhl, MD
University of California, Los Angeles (UCLA)
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital